# Intraligmentary Dexamethasone in Lower First Molars With Irreversible Pulpitis and Apical Periodontits

> **NCT05928611** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 81 (estimated)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **PROCEDURE:** Inferior alveolar nerve block with dexamethasone
- **PROCEDURE:** Buccal infiltratation with dexamethasone
- **PROCEDURE:** Inferior alveolar nerve block

## Key facts

- **NCT ID:** NCT05928611
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-08
- **Primary completion:** 2024-05
- **Final completion:** 2024-09
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05928611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05928611, "Intraligmentary Dexamethasone in Lower First Molars With Irreversible Pulpitis and Apical Periodontits". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05928611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*